@vikasbargale Sir
The information published on Screener doesn’t seem to be accurate. From what I could gather from BSE filings, Orbimed exited from one fund and took entry into a different fund (while increasing their stake from 9.8% to 12.08%). Motilal Oswal most likely brokered this transaction. Source: Bulk/block deals data from BSE.
Disclaimer: Invested, biased
Subscribe To Our Free Newsletter |